Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Torii

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Torii's Japan sales performance.

AZ’s Imfinzi plus tremelimumab combo misses again

AZ’s Imfinzi plus tremelimumab combo misses again The FDA is due to deliver a verdict on Imfinzi in extensive-stage SCLC in the first half of 2020, with decision in Europe and Japan – and a regulatory filing in

Genmab hires first chief operating officer

Genmab hires first chief operating officer Mancini will be based in Princeton, New Jersey, US but will also travel regularly to Genmab’s sites in Copehagen, Denmark; Utrecht, The Netherlands; and Tokyo, Japan.

Shionogi makes buyout play for Tetra ahead of Alzheimer’s readout

Shionogi makes buyout play for Tetra ahead of Alzheimer’s readout Fifteen months ago Shionogi signed a $160m deal with Tetra for regional rights to BNP14770 in Japan, Korea and Taiwan, with an upfront payment of $5m and a $35m equity investment.

FDA approves Allergan’s biodegradable glaucoma implant drug

FDA approves Allergan’s biodegradable glaucoma implant drug One company looking to develop novel treatments for the ocular disorder is UK gene therapy company Quethera – which was acquired in 2018 by Japan’s Astellas Pharma.

GSK seeks EU approval for Trelegy in adult asthma patients

GSK seeks EU approval for Trelegy in adult asthma patients The drug is already approved in Japan, and is due for regulatory decisions in Europe and the US this year. ... Trelegy is also under FDA review for asthma in the US, and in Japan, with both review process currently ongoing.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics